Diabetes Professional Care

CVRM Professional Care 2026 (Diabetes Professional Care)

Event dates: 20–21 October 2026
Venue: Olympia, London
Country: United Kingdom
Event focus (as stated by the organizer): The UK’s largest event focusing on the holistic care and the management of long-term conditions, combining cardiovascular, renal and metabolic care—explicitly including diabetes, and overweight/obesity—under one roof.

This is a two-day exhibition and conference positioned for UK healthcare professionals only. The event describes itself as bringing together clinicians and health professionals to share expertise across cardio-renal-metabolic management, with education, innovation and networking intended to improve patient outcomes across the NHS and beyond.

1️⃣ Who attends (BUYERS / ATTENDEES)

The event is clearly designed for UK healthcare professionals only. That means the “attendee” population is primarily clinical and healthcare decision-making stakeholders, rather than general industry visitors.

Attendee / buyer reality check: At events like this, the most monetizable and highest-conversion buyer profiles are typically the people influencing (or directly owning) clinical pathways, formularies, service development, procurement narratives, education priorities, and adoption of clinical innovations within NHS and associated healthcare settings.

Primary attendee groups we should expect (based on the organizer’s description):

• Clinicians and healthcare professionals involved in long-term condition management (with a core emphasis on diabetes plus cardio-renal-metabolic overlap).
• Multi-specialism clinicians spanning cardiovascular, renal and metabolic care (including diabetes and obesity/overweight).
• NHS-connected healthcare stakeholders focused on prevention, proactive care, and improved patient outcomes.
• Speakers and sector leaders (the event references 60 speakers, indicating a clinical expert-led programme structure).
• Exhibiting organizations and sponsors operating in pharmaceutical and med tech sectors via grants/sponsorship/exhibition packages.

Who is most likely to be the best “buyer” match for an attendee/visitor database: roles that sit near clinical programme design, diabetes pathway improvement, service delivery for long-term conditions, education and guideline implementation, and adoption of therapies and devices.

2️⃣ Where the show is happening + attendee geographic origin

Where the show is happening: Olympia, London, United Kingdom.

Attendee geographic origin (reliably stated vs. not stated):
The organizer’s site explicitly confirms the UK-only healthcare professional audience, but it does not provide a quantified breakdown of county/region/city origin on the excerpt provided.

Practical geographic expectation for targeting (without claiming exact percentages):
Because it is branded as the UK’s largest cardio-renal-metabolic conference and trade show, the attendee catchment is highly likely to be nationwide across the UK (England, Scotland, Wales, Northern Ireland), with London hosting a large portion of in-person attendance.

Best targeting regions for outreach (useful for buyer list building): UK-wide healthcare systems and organizations, with additional emphasis on stakeholders likely to travel to London for high-impact conferences.

3️⃣ Audience reach (Local / National / Global)

The event is positioned as the UK’s largest event in this space and explicitly targets UK healthcare professionals only.

Conclusion: This is best categorized as National (UK) reach, with a strong conference network effect through the UK’s healthcare ecosystem. The provided text does not state a global attendee component, so we should not assume international footfall.

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

The organizer states the event is sponsored by the pharmaceutical and med tech industries through grants, sponsorship and exhibition packages. Using that category, below is a structured starting list of buyer-style organizations that typically participate in diabetes, cardio-renal-metabolic conferences and NHS-focused stakeholder events.

Important: The excerpt does not provide the confirmed exhibitor/sponsor list. So the table below is a buyer-targeting shortlist that fits the stated sponsor industries, not a verified exhibitor list from the organizer site excerpt.

Top “send first” buyer shortlist (if we need a condensed start):
Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Dexcom.

5️⃣ Job profiles, industries & event type

Event type (from the organizer’s positioning):

• Healthcare conference with a dedicated trade show / exhibition
• Cardio-renal-metabolic clinical education event (explicitly includes diabetes)
• Professional-only audience (UK healthcare professionals only)
• Sponsored by pharmaceutical and med tech industries with exhibition and speaker-supported sessions

Most relevant job profiles to target (buyer decision influence):

• Medical Affairs Director / Head of Medical Affairs (Diabetes, Endocrinology, Metabolic)
• UK Diabetes / Endocrinology Clinical Lead
• Cardio-Renal-Metabolic Therapy Area Lead
• Medical Science Liaison (MSL) / Senior MSL (UK territory)
• Market Access Lead / Health Economics & Outcomes (HEOR) Manager
• Clinical Evidence & Outcomes Lead / Value & Evidence Manager
• Healthcare Professional Engagement Lead (UK)
• Commercial Director, Diabetes / Metabolic / CVRM (UK)
• Partnerships Manager for NHS / Clinical Collaborations
• Diagnostics or Technology Partnerships Lead (if device/diagnostics-focused)

Industries we should align with (using your provided industry list):

• Pharmaceuticals
• Medical Devices
• Hospital & Health Care
• Renewables & Environment (only if the client product is unrelated—generally not applicable here; we would not prioritize this)
• Research (if sponsor participation is evidence/clinical research driven)
• Marketing & Advertising (only for healthcare engagement functions; secondary)
• Program Development (if sponsor roles build clinical education programmes)
• Professional Training & Coaching (if sponsor-led clinician education is a key component)

Best-fit industry selection for buyer list building:
Pharmaceuticals + Medical Devices + Hospital & Health Care + Research.

6️⃣ Estimated attendance (expected total footfall)

The provided official excerpt states:

• 1,500 healthcare professionals
• 60 speakers
• 4 newly designed theatres

The excerpt does not explicitly provide an overall “total footfall” number that includes exhibitors/sponsors, delegates beyond the 1,500, and trade show-only visitors. Therefore, we should treat 1,500 healthcare professionals as the most reliable stated attendance indicator from the provided content.

Working estimate approach for planning (without inventing a number):
Use 1,500 healthcare professionals as the anchor attendance metric for targeting buyer-relevant contacts, and validate any additional exhibitor/sponsor visitor counts using the official exhibitor/visiting pages if available in the full site.

7️⃣ Key focus areas & buyer engagement

Key focus areas (explicitly stated by the organizer):

• Holistic care and management of long-term conditions
• Integration of cardiovascular, renal and metabolic care under one event
• Diabetes and overweight/obesity included within the CVRM framework
• Support for prevention and proactive care
• Improving patient outcomes across the NHS and beyond
• Collaboration between specialisms (moving away from siloed long-term condition models)

Buyer engagement angles that typically perform best here (based on the stated programme intent):

• Clinical education value: Medical affairs and clinical teams want credible, evidence-based session sponsorship and speaker engagement (the site notes that sessions with sponsor input will be marked on the programme).
• NHS pathway relevance: Messaging should emphasize service transformation, long-term condition pathways, and proactive management.
• Cross-specialism alignment: Because the event unites cardio-renal-metabolic care, buyer engagement should reflect integrated care rather than “diabetes-only” messaging.
• Innovation with practical outcomes: The organizer explicitly mentions education, innovation and networking aimed at improving outcomes.
• Long-term condition framework: Engagement should speak to patient experience across diabetes, cardiovascular disease, renal needs and metabolic risks.

8️⃣ Client-product fit + request to review client website (to identify the best buyers)

We can refine “best buyers” precisely, but we need the client’s product context. Right now, we only know the event’s sponsor industries (pharmaceutical and med tech) and the clinical themes (CVRM with diabetes/obesity).

Please share the client website URL (and ideally a 2–3 line product summary).

Once we review the client website, we will map the product to the most relevant buyer segments and provide:

• Which buyer roles are most likely to buy/support the solution at this type of conference
• Whether the best buyer set skews toward pharma medical affairs, market access/HEOR, diabetes technology adoption, or diagnostics/clinical workflow
• A tightened priority list of buyer company types and the most suitable job titles

For now (provisional buyer fit logic based on the official event positioning):

• If the client product is diabetes therapeutics or metabolic care → prioritize Medical Affairs + Market Access + Clinical Evidence titles in Pharmaceuticals.
• If the client product is diabetes devices, monitoring technologies, or med-tech for chronic care → prioritize UK Clinical Engagement + Partnerships + Outcomes/V&E titles in Medical Devices.
• If the client product is diagnostics or clinical decision support → prioritize Diagnostics Partnerships + Evidence/Outcomes + Clinical Workflow adoption titles.
• If the client product is education, training, or clinical programme support → prioritize Programme Development, Professional Training/Coaching adjacent roles and Healthcare Professional Engagement leads.

If you share the website, we will replace the provisional mapping with a definitive buyer prioritization that matches the client’s actual offering.

9️⃣ Final recommendation (for attendee-list / buyer-list research)

CVRM Professional Care 2026 is a strong fit for buyer-focused research because:

• It has a clearly defined UK healthcare professional only gate, improving audience relevance quality.
• It includes diabetes explicitly within a broader cardio-renal-metabolic framework—ideal for integrated long-term condition solutions.
• It is supported by pharmaceutical and med tech sponsorship structures, indicating commercial interest and exhibitor presence.
• The event states 1,500 healthcare professionals and a multi-theatre conference format, suggesting meaningful density for education-driven engagements.

Recommended best buyer shortlist approach (until we review your client website):
Target the top 5 company types first: Diabetes-focused pharma, CVRM-integrated pharma, diabetes med-tech, diagnostics/clinical evidence vendors, and UK market access/HEOR-focused pharma affiliates.

Next step: Please send your client website so we can identify the best buyer companies and best job titles for this specific product context.